Your cart is empty now.
MCO™ Tech. (Minimising Cross-linking-agent by Optimising reaction Technology) is a technology developed by Koru Pharma’s R&D Institute.
The cross-linking agent serves to connect hyaluronic acid chains to form a net.
By optimising cross-linking reaction conditions in which a chemical reaction between the cross-linking agent and HA occurs, the use of the cross-linking agent is minimised, thereby maximising the efficiency of the cross-linking reaction.
*The duration of effect might vary depending on the individual physical characteristics of the patient, injection method and type of the procedure.
Easy correction of deep wrinkles
Absolutely safe for use in the face and body
No edema or inflammations
Improvement of complexion
Suitable for patients with sensitive skin
Volume loss in soft tissue
Undefined facial contours
Volume loss in the temporal, zygomatic, and nasal areas
Aesthetic defects in cheeks and chin areas, correction of mandibular angle